Newly diagnosed rheumatoid arthritis

Por Weisman, M
Publicado em 2002

Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis.

Por Weisman, M, Zvaifler, N
Publicado em 1975

Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases

Por Hallegua, D, Weisman, M
Publicado em 2002

Activation of the alternate complement pathway in Staph. aureus infective endocarditis and its relationship to thrombocytopenia, coagulation abnormalities, and acute glomerulonephr...

Por O'Connor, D T, Weisman, M H, Fierer, J
Publicado em 1978

Long term safety of etanercept in elderly subjects with rheumatic diseases

Por Fleischmann, R, Baumgartner, S W, Weisman, M H, Liu, T, White, B, Peloso, P
Publicado em 2006

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

Por Vitali, C, Bombardieri, S, Jonsson, R, Moutsopoulos, H, Alexander, E, Carsons, S, Daniels, T, Fox, P, Fox, R, Kassan, S, Pillemer, S, Talal, N, Weisman, M
Publicado em 2002

Infliximab in active early rheumatoid arthritis

Por Breedveld, F, Emery, P, Keystone, E, Patel, K, Furst, D, Kalden, J, St, C, Weisman, M, Smolen, J, Lipsky, P, Maini, R
Publicado em 2004

High score on PREDICTS is associated with 10-fold increased odds for the progression of subclinical atherosclerosis in SLE

Por McMahon, M, Sahakian, Lori, Grossman, J, Skaggs, B, Fitzgerald, J, Charles-Schoeman, C, Ragavendra, N, Gorn, A, Karpouzas, G, Weisman, M, Wallace, D, Hahn, B
Publicado em 2012

The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year

Por Kavanaugh, A, Antoni, C E, Gladman, D, Wassenberg, S, Zhou, B, Beutler, A, Keenan, G, Burmester, G, Furst, D E, Weisman, M H, Kalden, J R, Smolen, J, van der Heijde, D
Publicado em 2006

Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)

Por Furst, D, Breedveld, F, Kalden, J, Smolen, J, Burmester, G, Dougados, M, Emery, P, Gibofsky, A, Kavenaugh, A, Keystone, E, Klareskog, L, Russell, A, van de Putte, L B A, Weisman, M
Publicado em 2003

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006

Por Furst, D E, Breedveld, F C, Kalden, J R, Smolen, J S, Burmester, G R, Emery, P, Keystone, E C, Schiff, M H, van Riel, P L C M, Weinblatt, M E, Weisman, M H
Publicado em 2006

Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000)

Por FURST, D, BREEDVELD, F, BURMESTER, G, CROFFORD, J, EMERY, P, FELDMANN, M, KALDEN, J, KAVANAUGH, A, KEYSTONE, E, KLARESKOG, L, LIPSKY, P, MAINI, R, RUSSELL, A, SCOTT, D, SMOLEN, J, VAN DE PUTTE, L B A, VISHER, T, WEISMAN, M
Publicado em 2000

Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007

Por Furst, D E, Breedveld, F C, Kalden, J R, Smolen, J S, Burmester, G R, Sieper, J, Emery, P, Keystone, E C, Schiff, M H, Mease, P, van Riel, P L C M, Fleischmann, R, Weisman, M H, Weinblatt, M E
Publicado em 2007

Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis

Por Cortes, A, Maksymowych, W P, Wordsworth, B P, Inman, R D, Danoy, P, Rahman, P, Stone, M A, Corr, M, Gensler, Lianne S, Gladman, D, Morgan, A, Marzo-Ortega, H, Ward, M M, Learch, T J, Reveille, J D, Brown, M A, Weisman, M H
Publicado no Ann Rheum Dis (2014)

Minimally important difference in diffuse systemic sclerosis: results from the d‐penicillamine study

Por Khanna, D, Furst, D E, Hays, R D, Park, G S, Wong, W K, Seibold, J R, Mayes, M D, White, B, Wigley, F F, Weisman, M, Barr, W, Moreland, L, Medsger, T A, Steen, V D, Martin, R W, Collier, D, Weinstein, A, Lally, E V, Varga, J, Weiner, S R, Andrews, B, Abeles, M, Clements, P J
Publicado em 2006